Home
HelpTest Code JAK2O JAK2 V617F Mutation (Exon14) assay (Blood)
Specimen and Container/Tube
Blood
Rejection Criteria
Inappropriate anticoagulant and >72 hours
Clinical Indications
May be used to diagnose and manage myeloproliferative
neoplasms
including polycythemia vera, essential thrombocythemia, primary
myelofibrosis and other
myeloproliferative disorders.
Test Components
Detects JAK2 V617F Mutation in Exon 14
Methodology
Real time PCR
Test Includes
Detects JAK2 V617F Mutation in Exon 14
Specimen Type
Blood
Preferred Volume
3 mL
Turnaround Time
Not Available
Test Usage
May be used to diagnose and manage myeloproliferative
neoplasms
including polycythemia vera, essential thrombocythemia, primary
myelofibrosis and other
myeloproliferative disorders.
Fee Code
376555-30081270
Synonyms
MPN JAK2
Offsite Collection Instructions
Send within 24 hours or Refrigerate/ send within 72 hours
UCMC Collection Instructions
Send within 72 hours
Test Limitations
Will not detect JAK positive
cells
below sensitivity of assay (2% variant allele frequency) or
other
JAK2 mutations.
STAT Turnaround Time
Not Available
Container/Tube
Lavender top
Specimen Minimum Volume
1 mL
Special Instructions
Send within 72 hours
Day(s) Performed
Monday – Friday, 8:00 AM – 4:30 PM
STAT DAY(S) AND TIME(S) PERFORMED
No
CPT
81270
Method Name
Real time PCR
Reference Values
Interpretative report
Reject Due To
Inappropriate anticoagulant and >72 hours
Pediatric Volume
1 mL
Transport Instructions
Send within 24 hours or Refrigerate/ send within 72 hours
Synonyms/Key Search Words
MPN JAK2